ELCC 2024 wrapped up over the weekend and we’ve compiled the latest post-conference insights, highlighting the top trials as discussed by leading oncologists on X. 🌟 Learn more about LARVOL CLIN and explore our key insights here: https://bit.ly/3TTUFwc. #ELCC2024 #LARVOL #Oncology #Research
LARVOL’s Post
More Relevant Posts
-
Highlighting more insights from AACR 2024! 💫 LARVOL CLIN has been compiling the latest post-conference insights, highlighting the top trials as discussed by 2500+ leading oncologists on X. Explore more analytics here: https://bit.ly/3vWSleR #AACR2024 #LARVOL #CancerResearch #Oncology
To view or add a comment, sign in
-
Working towards a better understanding of immuno-oncology? Listen to this chat of a panel of scientists who are researching towards understanding CAR-T therapy patient factors. Watch on-demand now: https://ow.ly/NqOq50QtoNt #flowcytometry #oncology #EmoryMedicine #immunooncology
To view or add a comment, sign in
-
Join my colleagues from Inizio Medical for a webinar on June 27th where we will dive into the most talked-about topics from #ASCO24, provide in-depth analysis, and highlight key takeaways - this is not to be missed! Learn more and register here: https://lnkd.in/e3pr9aEG #MRX #ResearchPartnership #Oncology #Webinar
To view or add a comment, sign in
-
The drug discovery process is more complex than ever. In our latest poll, we asked what you find to be the greatest challenge you face for #clinicaltrials. Increasing trial complexity was 1 of the top 2 answers. Trust MERIT's tenured specialists to provide robust, personalized service and to proactively manage the imaging requirements of your study. Learn more: https://lnkd.in/dWkJRyMu #MERITCRO #YourClinicalEndpointExpert #ophthalmology #oncology
To view or add a comment, sign in
-
Enhance your Molecular Tumor Board with datma.360 visualization tool that augments your EHR, integrating fragmented healthcare data (including omics, clinical and imaging data) that currently impedes comprehensive patient analysis. This facilitates actionable insights for personalized medicine and helps prevent gaps in patient care. Revolutionize how you manage complex molecular diagnostic data in oncology and experience the future of precision medicine with Molecular Tumor Boards powered by datma.360. Reach out for a demo today! #oncology #precisionmedicine #ai #healthcareinnovation #moleculartumorboards #genomics #tumorboard #datma
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
To view or add a comment, sign in
-
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
To view or add a comment, sign in
-
Looking forward to next week at Tumor Models Boston! If you're there also and want to learn about the Translational Drug Development (TD2) Difference, stop by our booth and let's chat! #benchtobedside #preclinical #nonclinical #preclinicaldevelopment #bioanalytical #regulatorconsulting #clinicaltria #cancertherapeutic #cancerresearch #oncologyresearch #td2
Don't miss us next Tuesday at the 12th Annual Tumor Models Boston Summit, and come check out our presentation at 2:00 PM ET! Reach out to schedule a meeting here: https://hubs.li/Q02F-sg_0 #TumorModels #Oncology #TD2
To view or add a comment, sign in
-
We're happy to share that Tomasz Jankowski, MD, PhD, the presenting author of MAIA’s poster at #ASCO24 and the key investigator in MAIA's Phase 2 #clinicaltrial, was selected as one of the very few authors to provide a video update. Watch Dr. Jankowski’s discussion about the progress of THIO-101 here: https://bit.ly/3RExJja #ClinicalResearch #Oncology #NSCLC
To view or add a comment, sign in
-
The recent meeting in San Antonio covered many exciting #breastcancer abstracts, including️ KEYNOTE-756, KEYNOTE-522, neoMono, and more! Compare and contrast the emerging therapies discussed in these studies and earn free #CME: https://bit.ly/3woF8ez #MedEd #FOAMed #Oncology
To view or add a comment, sign in
-
Receive expert guidance on the evolving role of adjuvant CDK4/6 inhibition to help patients with HR+ early #BreastCancer derive maximum benefit in a new #MedEd activity with @DrAdityaBardia developed with partners @PeerView & @LivingBeyondBC: https://bit.ly/3wEdLgX #Oncology
To view or add a comment, sign in
11,660 followers
Try us